Researchers at University of California San Diego School of Medicine discovered that they can block inflammation in mice with a naturally occurring antibody that binds oxidized phospholipids (OxPL), molecules on cell surfaces that get modified by inflammation. Even while on a high-fat diet, the antibody protected the mice from arterial plaque formation, hardening of the arteries and liver disease, and prolonged their lives.
This study, published June 6 by Nature, marks the first demonstration in a living system that OxPL triggers inflammation and leads to plaque formation. The results also suggest a new approach for preventing or reversing a number of inflammatory diseases.
“Wherever you get inflammation, you get OxPL,” said senior author Joseph Witztum, MD, professor of medicine at UC San Diego School of Medicine. “It doesn’t mean OxPL is the cause, but it definitely plays a major role.” Witztum led the study with first author Xuchu Que, PhD, a senior project scientist at UC San Diego School of Medicine.
Some phospholipids — the molecules that make up cell membranes — are prone to modification by reactive oxygen species, forming OxPL. This event is particularly common in inflammatory conditions such as atherosclerosis, in which artery-blocking plaques form. Prior to this study, researchers were unable to control phospholipid oxidation in a way that would allow them to study its role in inflammation and atherosclerosis.
Witztum, Que and team engineered mice with two special attributes: 1) they have a gene mutation that makes them a good model for atherosclerosis and 2) they generate a piece of an antibody called E06 that’s just enough to bind OxPL and prevent their ability to cause inflammation in immune cells, but not enough to cause inflammation on its own. They fed the mice a high-fat diet.
Here’s what happened: Compared to control mice, the mice with E06 antibodies had 28 to 57 percent less atherosclerosis, even after one year and despite having high levels of cholesterol. The antibody also decreased aortic valve calcification (hardening and narrowing of the aortic valves), hepatic steatosis (fatty liver disease) and liver inflammation. E06 antibody-producing mice had 32 percent less serum amyloid A, a marker of systemic inflammation.
The E06 antibody also prolonged the life of the mice. After 15 months, all of the E06 antibody-producing mice were alive, compared to 54 percent of the control mice.
“We showed for the first time that OxPL are truly pro-inflammatory and pro-atherogenic and, moreover, that they can be counteracted by E06 antibody,” Witztum said. “This suggests that therapies that inactivate OxPL may be beneficial for reducing inflammation in general, and in particular in the case of diseases such as atherosclerosis, aortic stenosis and hepatic steatosis.”
Witztum and team are now testing E06 antibody in mouse models of human diseases linked to inflammation, such as osteoporosis (bone loss) and nonalcoholic steatohepatitis (NASH, a type of liver disease).
Receive an email update when we add a new INFLAMMATION article.
The Latest on: Inflammation
via Google News
The Latest on: Inflammation
- SLU researchers explore how fetal exposure to inflammation can alter immunity in newborns on December 11, 2018 at 9:34 pm
Saint Louis University researchers are studying how fetal exposure to inflammation can alter immune responses after birth. Joyce Marie Koenig, M.D., professor of pediatrics and molecular microbiology ... […]
- This 7-Ingredient Recipe Is an All-Natural Fighter Against Inflammation on December 11, 2018 at 3:36 pm
Chronic inflammation causes a host of unpleasant symptoms, from fatigue to pain. If you deal with chronic inflammation, you know that (luckily) certain foods, tonics, and natural remedies can help. Tr... […]
- Unique immune cell likely drives chronic inflammation on December 11, 2018 at 9:25 am
For the first time, researchers have identified that an immune cell subset called gamma delta T cells that may be causing and/or perpetuating the systemic inflammation found in normal aging in the gen... […]
- Researchers discover unique immune cell likely drives chronic inflammation on December 11, 2018 at 8:32 am
For the first time, researchers have identified that an immune cell subset called gamma delta T cells that may be causing and/or perpetuating the systemic inflammation found in normal aging in the ... […]
- Beyond Advil: Chronic Inflammation. This Could Be Why You Feel Like That on December 11, 2018 at 5:50 am
Advil is a best friend to many: too many burpees? (ok, sure..) cramps from your period, your a.m. Iron training? A few too many scorpion bowls on the lunch hour? It’s all about inflammation. […]
- Emerging Studies Show Berberine Reduces Cigar Smoke Inflammation on December 11, 2018 at 1:31 am
According to some studies, this alkaloid compound has anti-inflammatory properties. It is important to remember that inflammation has long been linked with a range of symptoms, diseases, and ... […]
- The Lectin-Free Diet Says Some Veggies Cause Inflammation—but Does It Work? on December 10, 2018 at 12:52 pm
Move over, gluten. There’s a new something that could be the cause of all your wellness woes: Lectins. A naturally occurring protein, lectins are found in beans, legumes, whole grains, and some vegeta... […]
- Snacking Could Cause Inflammation, Harming Your Health on December 6, 2018 at 4:16 am
Only until relatively recently in human evolution have we eaten three meals plus snacks every day. Breakfast simply didn’t exist for large parts of history. The Romans, for example, didn’t eat it – us... […]
- Myocardial inflammation frequent in RA, linked to disease activity on December 6, 2018 at 2:33 am
Researchers found that subclinical myocardial inflammation occurs frequently in rheumatoid arthritis, is associated with disease activity and could potentially be alleviated with rheumatoid arthritis ... […]
via Bing News